Figure 5
From: Endocan as a marker of microvascular inflammation in kidney transplant recipients
Renal allograft survival of enrolled patients. (A) Renal survival according to the diagnosis. (B–D) Renal survival according to plasma and urinary endocan levels in (B) acute T-cell mediated rejection, (C) acute antibody-mediated rejection, and (D) chronic active antibody-mediated rejection group. Plasma and urinary endocan levels were integrated by binary regression analysis.
